Obamacare Cut Racial Disparities in Cancer Care Time to cancer treatment evens in blacks and whites with Medicaid expansion Jun 03, 2019
Trials Back Earlier Use of Androgen Receptor Inhibitors Improved survival in metastatic hormone-sensitive prostate cancer Jun 03, 2019
Add-On Metformin Disappoints in Metastatic CRPC No meaningful clinical benefit when paired with docetaxel-prednisone in castration-resistant prostate cancer Jun 02, 2019
POLO Will Change Practice in Pancreatic Cancer "Huge step forward" for metastatic disease, says expert Jun 02, 2019
Dramatic OS Boost With Kisqali in Young Breast Ca Patients 'First study to demonstrate improved survival for a targeted therapy' in advanced disease Jun 02, 2019
Front-Line Keytruda: The New Standard in Gastric Ca Tx? Pembrolizumab leads to comparable survival outcomes versus chemo Jun 01, 2019
Low-Dose Tx Wins in Older Gastroesophageal Ca Patients Overall survival maintained with gains in quality of life May 15, 2019
Ditching Chemo Appears Viable in Frontline Follicular Lymphoma PFS 'nearly identical' at 3 years with novel immunomodulatory combination Jun 06, 2018
PFS Rises in Ovarian Ca with Repeat Bevacizumab Magnitude of benefit similar to first-line therapy Jun 06, 2018
Quick Intervention Improves Care in Geriatric Cancer Patients Randomized trial improved oncologist-patient communication Jun 06, 2018
Less Morbidity, Lower Costs Tied to MIS in Cervical Cancer But minimally invasive surgery also linked to decreased survival Jun 05, 2018
IMPACT Trial: Support for Targeted Cancer Tx Approaches Survival doubled with therapy matched to tumor genetics Jun 05, 2018
Pancreatic Ca Gets 20-Month Survival Boost Aggressive post-surgery chemo regimen touted as new standard of care Jun 05, 2018
Pre-Surgical CRT May Boost Survival in Pancreatic Ca Further data needed to clarify best approach and who would benefit most Jun 04, 2018
Many with Metastatic Kidney Cancer Can Skip Surgery Overall survival with single-agent sunitinib better than with resection Jun 04, 2018
Hot Chemo Fails in Rare Cancer HIPEC and surgery equals surgery alone in peritoneal carcinomatosis Jun 04, 2018
Rare Childhood Cancer Gets First Tx Advance in 30 Years But impact unclear for U.S. rhabdomyosarcoma patients Jun 04, 2018
Keytruda Alone Bests Chemo in Advanced NSCLC Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations Jun 04, 2018
Ivosidenib Induces Deep Remissions in IDH1-Mutant AML On strength of phase I data, drug appears headed for FDA approval Jun 03, 2018
PI3K Inhibitor Has Mixed Results in Advanced Breast Cancer Modest progression benefit, but substantial side effects, with taselisib Jun 03, 2018
Women Get Less Aggressive Tx for Head and Neck Ca Registry data find that women are less likely to receive chemotherapy or radiation than men Jun 01, 2018
Lung Cancer Screening Rates Disappoint Evidence shows benefit for high-risk smokers but few get tested May 17, 2018
CBT Tops Acupuncture for Treating Insomnia in Cancer Survivors But both methods provide alternative to sleeping pills May 17, 2018
Six Months of Trastuzumab Equal to 12 in Breast Ca Similar outcomes and less cardiotoxicity, but more research needed May 16, 2018
Another CDK4/6 Inhibitor Boosts PFS in Breast Cancer Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease Jun 08, 2017
No Survival Benefit with Node Dissection in Ovarian Ca Macroscopic complete resection drives outcomes Jun 07, 2017
Two Anti-HER2 Drugs Slightly Better Than One Patient selection key to addition of pertuzumab to trastuzumab Jun 07, 2017
Genomic Testing Helps Cancer Patients -- When Results are Used Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
Dacomitinib Sets PFS Record in Phase III NSCLC Trial Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy Jun 06, 2017
Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients Jun 05, 2017
Advanced Ca Patients Benefit from Online Symptom Reports Patient-reported outcomes tied to increased survival Jun 05, 2017
Trastuzumab Copycat Has Similar Efficacy Phase III trial compared substances in early-stage breast cancer Jun 05, 2017
Big Win for PARP Inhibitor in Breast Cancer PFS boost for HER2-negative, BRCA-mutated disease Jun 05, 2017
Short-Course RT Helps Retain Ability to Walk in Advanced Ca Preferable to multi-dose radiotherapy for spinal cord compression Jun 04, 2017
Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
Mixed Results with Novel Tx in Sarcoma Aldodoxorubicin can't boost PFS, but promising in L-sarcomas Jun 03, 2017
Abiraterone Combo: A New Care Standard in Prostate Cancer? Earlier treatment appears to improve survival in metastatic disease Jun 03, 2017
Second Surgery Slows Recurrent Ovarian Cancer But no survival gain seen in interim analysis of DESKTOP III Jun 03, 2017
